Literature DB >> 4134959

Brain-decarboxylase activities as indices of pathological change in senile dementia.

D M Bowen, P White, R H Flack, C B Smith, A N Davison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4134959     DOI： 10.1016/s0140-6736(74)90003-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.

Authors:  Richard B Silverman
Journal:  J Med Chem       Date:  2012-01-10       Impact factor: 7.446

2.  Glutamate and GABA-metabolizing enzymes in post-mortem cerebellum in Alzheimer's disease: phosphate-activated glutaminase and glutamic acid decarboxylase.

Authors:  G Sh Burbaeva; I S Boksha; E B Tereshkina; O K Savushkina; T A Prokhorova; E A Vorobyeva
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

3.  Trial of levodopa in senile dementia.

Authors:  C Lewis; B R Ballinger; A S Presly
Journal:  Br Med J       Date:  1978-03-04

4.  Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors.

Authors:  Hejun Lu; Richard B Silverman
Journal:  J Med Chem       Date:  2006-12-14       Impact factor: 7.446

Review 5.  Development of pharmacological treatments for Alzheimer-type dementia.

Authors:  J Cornwall; T H Corn
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

6.  Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens.

Authors:  S Sorbi; P Antuono; L Amaducci
Journal:  Ital J Neurol Sci       Date:  1980-03

Review 7.  Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment.

Authors:  C G Gottfries
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 8.  Clinical trials in Alzheimer's disease. A report from the Medical Research Council Alzheimer's Disease Clinical Trials Committee.

Authors:  M Swash; D N Brooks; N E Day; C D Frith; R Levy; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

9.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Authors:  E K Perry; B E Tomlinson; G Blessed; K Bergmann; P H Gibson; R H Perry
Journal:  Br Med J       Date:  1978-11-25

Review 10.  Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.

Authors:  Karan Govindpani; Beatriz Calvo-Flores Guzmán; Chitra Vinnakota; Henry J Waldvogel; Richard L Faull; Andrea Kwakowsky
Journal:  Int J Mol Sci       Date:  2017-08-21       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.